A freshly renegotiated deal with lenders and a second dividend cut in three months have given Penn West Petroleum Ltd. (NYSE:PWE) a small cushion as it struggles under a hefty layer of debt and low oil prices. The energy firm said Thursday it lost $1.77-billion in the fourth quarter and $1.733-billion for all of 2014, largely owing to writedowns in the last three months of the year. Penn West refrained from cutting its 2015 budget for a second time, but hinted it may trim its spending plan later this spring. On Thursday shares of Penn West Petroleum Ltd. (NYSE:PWE) closed at $1.52. Company’s sales growth for last 5 years was -12.70% and EPS growth for next 5 years is recorded as 9.30%.
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) provided an overview of the Company’s 2014 achievements and a business update for 2015. The stated achievements and highlights below demonstrate the significant progress the Company has made on key initiatives to support the advancement of the ongoing Phase 1/2 program and upcoming Phase 3 clinical development program for Actimab-A and Iomab-B, respectively. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) in last trading activity decreased -0.70% to close at $2.82. Company weekly performance is -7.24% while its quarterly performance stands at -53.00%. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is -81.20% away from its 52 week high.
The Madison Square Garden (NYSE:MSG) has earned a consensus recommendation of “Buy” from the eleven analysts that are currently covering the stock, StockRatingsNetwork.com reports. Six research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. On last trading day The Madison Square Garden Company (NASDAQ:MSG) moved up 1.24% to close at $76.81. Its volatility for the week is 1.15% while volatility for the month is 1.26%. MSG’s sales growth for past 5 years was 7.90% and its EPS growth for past 5 years was 31.80%. The Madison Square Garden Company (NASDAQ:MSG) monthly performance is -2.25%.
Molecular diagnostics company CombiMatrix Corp. (NASDAQ:CBMX) Thursday announced that the Superior Court of the State of California, County of Orange dismissed Relator Michael Strathmann’s claims and ruled in favour of the defendants Acacia Research Corp., its subsidiary CombiMatrix Corp. and Amit Kumar. The court said the Plaintiff failed to prove that Defendants had any fraudulent intent when they pursued insurance benefits under the National Union D&O Policy over a decade ago. The Realtor can appeal the verdict in next 60 days. On Thursday shares of CombiMatrix Corporation (NASDAQ:CBMX) closed at $2.01. Company’s sales growth for last 5 years was 0.30%.
On March 12, Stein Mart Inc. (NASDAQ:SMRT) announced financial results for the fourth quarter and fiscal year ended January 31, 2015. Operating income for the fourth quarter was $20.5 million compared to $10.7 million in 2013. Adjusted operating income for the fourth quarter was $23.7 million, up 11.3 percent from $21.3 million in 2013 (see Note 1). Net income for the fourth quarter was $12.3 million or $0.27 per diluted share compared to net income of $7.4 million or $0.16 per diluted share in 2013. Fourth quarter adjusted net income was $14.6 million or $0.32 per diluted share compared to adjusted net income of $14.0 million or $0.31 per diluted share in 2013. Stein Mart Inc. (NASDAQ:SMRT) in last trading activity advanced 0.24% to close at $12.40. Company quarterly performance stands at 27.97%. Stein Mart Inc. (NASDAQ:SMRT) is -3.58% away from its 52 week high.